Alerts will be sent to your verified email
Verify EmailABMINTLLTD
ABM International
|
Biogen Pharmachem
|
CCL International
|
|
---|---|---|---|
Operational Metrics
|
|||
Financials
|
|||
5 yr Average ROE
|
-9.49 % | 0.21 % | 2.82 % |
5yr average Equity Multiplier
|
1.78 | 1.01 | 1.58 |
5yr Average Asset Turnover Ratio
|
3.51 | 0.02 | 0.55 |
5yr Avg Net Profit Margin
|
-1.49 % | -19.83 % | 1.6 % |
Price to Book
|
4.73 | 0.67 | 1.21 |
P/E
|
0.0 | 0.0 | 79.13 |
5yr Avg Cash Conversion Cycle
|
15.17 Days | 0.0 | 190.64 Days |
Inventory Days
|
29.84 Days | 0.0 | 121.28 Days |
Days Receivable
|
15.07 Days | 0.0 | 124.06 Days |
Days Payable
|
28.04 Days | 1109.22 Days | 98.58 Days |
5yr Average Interest Coverage Ratio
|
16.94 | 902.8 | 1.31 |
5yr Avg ROCE
|
-8.62 % | 0.21 % | 5.11 % |
5yr Avg Operating Profit Margin
|
-1.63 % | -19.88 % | 7.39 % |
5 yr average Debt to Equity
|
0.14 | 0.0 | 0.4 |
5yr CAGR Net Profit
|
-6.61 % | n/a | -13.7 % |
5yr Average Return on Assets
|
-1.72 % | 0.21 % | 1.63 % |
Shareholdings
|
|||
Promoter Holding
|
74.7 % | 0.0 | 63.86 % |
Share Pledged by Promoters
|
0.0 | 0.0 | 1.63 % |
Change in Promoter Holding (3 Yrs)
|
0.0 | 0.0 | 7.31 % |
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
ABM International
|
Biogen Pharmachem
|
CCL International
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|